BR112015025474B1 - Dispositivo de irradiação, kit compreendendo o referido dispositivo, método de fabricação do mesmo, e uso de um precursor ou sal farmaceuticamente aceitável de um precursor de fórmula (i) - Google Patents
Dispositivo de irradiação, kit compreendendo o referido dispositivo, método de fabricação do mesmo, e uso de um precursor ou sal farmaceuticamente aceitável de um precursor de fórmula (i) Download PDFInfo
- Publication number
- BR112015025474B1 BR112015025474B1 BR112015025474-8A BR112015025474A BR112015025474B1 BR 112015025474 B1 BR112015025474 B1 BR 112015025474B1 BR 112015025474 A BR112015025474 A BR 112015025474A BR 112015025474 B1 BR112015025474 B1 BR 112015025474B1
- Authority
- BR
- Brazil
- Prior art keywords
- housing
- led lamp
- lamp system
- housing part
- power source
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- 239000002243 precursor Substances 0.000 title claims description 48
- 150000003839 salts Chemical class 0.000 title claims description 17
- 239000000203 mixture Substances 0.000 claims abstract description 69
- 238000002428 photodynamic therapy Methods 0.000 claims abstract description 62
- 239000012858 resilient material Substances 0.000 claims abstract description 38
- 238000003780 insertion Methods 0.000 claims abstract description 23
- 230000037431 insertion Effects 0.000 claims abstract description 23
- 238000011282 treatment Methods 0.000 claims description 135
- 239000003504 photosensitizing agent Substances 0.000 claims description 44
- 210000003679 cervix uteri Anatomy 0.000 claims description 37
- 230000008878 coupling Effects 0.000 claims description 37
- 238000010168 coupling process Methods 0.000 claims description 37
- 238000005859 coupling reaction Methods 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 33
- 230000005855 radiation Effects 0.000 claims description 27
- 238000000465 moulding Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 15
- -1 5-ALA hexyl ester Chemical class 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 8
- 238000005304 joining Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract description 28
- 229960002749 aminolevulinic acid Drugs 0.000 description 23
- 125000000217 alkyl group Chemical group 0.000 description 21
- 238000012377 drug delivery Methods 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 17
- 210000001215 vagina Anatomy 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 238000005286 illumination Methods 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 229920001296 polysiloxane Polymers 0.000 description 14
- 125000003118 aryl group Chemical group 0.000 description 13
- 210000004996 female reproductive system Anatomy 0.000 description 12
- 230000006378 damage Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 9
- 206010008342 Cervix carcinoma Diseases 0.000 description 8
- 241000701806 Human papillomavirus Species 0.000 description 8
- 208000009608 Papillomavirus Infections Diseases 0.000 description 8
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 201000010881 cervical cancer Diseases 0.000 description 8
- 235000014676 Phragmites communis Nutrition 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- 206010008263 Cervical dysplasia Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005192 partition Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 150000004032 porphyrins Chemical class 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 206010058314 Dysplasia Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 208000020082 intraepithelial neoplasia Diseases 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000012780 transparent material Substances 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 230000004308 accommodation Effects 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 208000009621 actinic keratosis Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007257 malfunction Effects 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 231100000760 phototoxic Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 2
- 101150070189 CIN3 gene Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000018777 Vulvar intraepithelial neoplasia Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 101150005988 cin2 gene Proteins 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 2
- 229940005608 hypericin Drugs 0.000 description 2
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 229940118199 levulan Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- YUUAYBAIHCDHHD-UHFFFAOYSA-N methyl 5-aminolevulinate Chemical compound COC(=O)CCC(=O)CN YUUAYBAIHCDHHD-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 230000002165 photosensitisation Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229950003776 protoporphyrin Drugs 0.000 description 2
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- OYINILBBZAQBEV-UWJYYQICSA-N (17s,18s)-18-(2-carboxyethyl)-20-(carboxymethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18,22,23-tetrahydroporphyrin-2-carboxylic acid Chemical compound N1C2=C(C)C(C=C)=C1C=C(N1)C(C)=C(CC)C1=CC(C(C)=C1C(O)=O)=NC1=C(CC(O)=O)C([C@@H](CCC(O)=O)[C@@H]1C)=NC1=C2 OYINILBBZAQBEV-UWJYYQICSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- ILBBNQMSDGAAPF-UHFFFAOYSA-N 1-(6-hydroxy-6-methylcyclohexa-2,4-dien-1-yl)propan-1-one Chemical compound CCC(=O)C1C=CC=CC1(C)O ILBBNQMSDGAAPF-UHFFFAOYSA-N 0.000 description 1
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical class N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 1
- KFKRXESVMDBTNQ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical class N1C2=C(C)C(C(C)O)=C1C=C(N1)C(C)=C(C(O)C)C1=CC(C(C)=C1CCC(O)=O)=NC1=CC(C(CCC(O)=O)=C1C)=NC1=C2 KFKRXESVMDBTNQ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 101150061050 CIN1 gene Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910002993 LiMnO2 Inorganic materials 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 201000003761 Vaginal carcinoma Diseases 0.000 description 1
- 206010046905 Vaginal dysplasia Diseases 0.000 description 1
- 206010047741 Vulval cancer Diseases 0.000 description 1
- KMWBBMXGHHLDKL-UHFFFAOYSA-N [AlH3].[Si] Chemical compound [AlH3].[Si] KMWBBMXGHHLDKL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000012635 anticancer drug combination Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000002573 colposcopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229940097294 hexaminolevulinate hydrochloride Drugs 0.000 description 1
- LZYXPFZBAZTOCH-UHFFFAOYSA-N hexyl 5-amino-4-oxopentanoate;hydron;chloride Chemical compound Cl.CCCCCCOC(=O)CCC(=O)CN LZYXPFZBAZTOCH-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007154 intracellular accumulation Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 201000002120 neuroendocrine carcinoma Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229940109328 photofrin Drugs 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N verteporfin Chemical compound C=1C([C@@]2([C@H](C(=O)OC)C(=CC=C22)C(=O)OC)C)=NC2=CC(C(=C2C=C)C)=NC2=CC(C(=C2CCC(O)=O)C)=NC2=CC2=NC=1C(C)=C2CCC(=O)OC ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N 0.000 description 1
- 229960003895 verteporfin Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
- 201000004916 vulva carcinoma Diseases 0.000 description 1
- 208000013013 vulvar carcinoma Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0605—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0607—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0608—Rectum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0611—Vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0632—Constructional aspects of the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201306369A GB201306369D0 (en) | 2013-04-09 | 2013-04-09 | Irradiation device |
| GB1306369.8 | 2013-04-09 | ||
| PCT/EP2014/057148 WO2014166993A1 (en) | 2013-04-09 | 2014-04-09 | Irradiation device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015025474A2 BR112015025474A2 (pt) | 2017-07-18 |
| BR112015025474B1 true BR112015025474B1 (pt) | 2022-09-06 |
Family
ID=48483569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015025474-8A BR112015025474B1 (pt) | 2013-04-09 | 2014-04-09 | Dispositivo de irradiação, kit compreendendo o referido dispositivo, método de fabricação do mesmo, e uso de um precursor ou sal farmaceuticamente aceitável de um precursor de fórmula (i) |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9974974B2 (https=) |
| EP (1) | EP2983780B1 (https=) |
| JP (2) | JP2016518904A (https=) |
| KR (1) | KR102295433B1 (https=) |
| CN (1) | CN105307722B (https=) |
| AU (1) | AU2014253175B2 (https=) |
| BR (1) | BR112015025474B1 (https=) |
| CA (1) | CA2908787C (https=) |
| CL (1) | CL2015002987A1 (https=) |
| ES (1) | ES2837025T3 (https=) |
| GB (1) | GB201306369D0 (https=) |
| MX (1) | MX375495B (https=) |
| NZ (1) | NZ630238A (https=) |
| RU (1) | RU2705606C2 (https=) |
| SG (1) | SG11201508117YA (https=) |
| WO (1) | WO2014166993A1 (https=) |
| ZA (1) | ZA201507529B (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0900461D0 (en) * | 2009-01-12 | 2009-02-11 | Photocure Asa | Photodynamic therapy device |
| US11207544B2 (en) | 2014-07-03 | 2021-12-28 | CERN Corporation | Light-based vaginal therapy device |
| US10004918B2 (en) | 2014-07-03 | 2018-06-26 | Gregg Alan Klang | LED based vaginal light therapy device |
| PL410162A1 (pl) | 2014-11-17 | 2016-05-23 | Wojskowa Akademia Techniczna | Oświetlacz LED z wyjściem światłowodowym |
| CN104941072A (zh) * | 2015-06-10 | 2015-09-30 | 上海世湖材料科技有限公司 | 一种智能遥控led阴道仪 |
| EP3313513B1 (en) * | 2015-07-02 | 2025-12-10 | Klang, Gregg, Alan | Light-based vaginal light therapy device |
| US10603508B2 (en) | 2015-10-15 | 2020-03-31 | Dusa Pharmaceuticals, Inc. | Adjustable illuminators and methods for photodynamic therapy and diagnosis |
| EP3362145B1 (en) | 2015-10-15 | 2021-01-06 | DUSA Pharmaceuticals, Inc. | Adjustable illuminator for photodynamic therapy and diagnosis |
| US20230200634A1 (en) * | 2016-09-25 | 2023-06-29 | Micronvision Corp. | Photodynamic therapy imaging |
| US11090082B2 (en) | 2017-05-12 | 2021-08-17 | Covidien Lp | Colpotomy systems, devices, and methods with rotational cutting |
| US11253308B2 (en) | 2017-05-12 | 2022-02-22 | Covidien Lp | Colpotomy systems, devices, and methods with rotational cutting |
| US11213320B2 (en) | 2017-05-12 | 2022-01-04 | Covidien Lp | Uterine manipulator with detachable cup and locking occluder |
| JP2020529298A (ja) * | 2017-07-27 | 2020-10-08 | セルン コーポレイションＣｅｒｎ Ｃｏｒｐ． | 光ベースの膣治療装置 |
| US10980571B2 (en) | 2017-08-15 | 2021-04-20 | Covidien Lp | Occlusion devices, systems, and methods |
| RU178421U1 (ru) * | 2017-09-25 | 2018-04-03 | Федеральное государственное автономное образовательное учреждение высшего образования "Северный (Арктический) федеральный университет имени М.В. Ломоносова" | Портативное устройство для светолечения |
| US10357567B1 (en) | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| US11344292B2 (en) | 2018-06-14 | 2022-05-31 | Covidien Lp | Trans-vaginal cuff anchor and method of deploying same |
| CN109350860B (zh) * | 2018-09-27 | 2021-01-01 | 李桂芬 | 一种医疗外科护理用烤灯及其使用方法 |
| IL285384B2 (en) | 2019-02-13 | 2024-11-01 | Alpheus Medical Inc | Non-invasive sonodynamic therapy |
| MX2021014512A (es) | 2019-05-29 | 2022-02-11 | Sonalasense Inc | Sonosensibilizacion. |
| US11291104B2 (en) | 2019-05-31 | 2022-03-29 | Fermi Research Alliance, Llc | Permanent magnet e-beam/x-ray horn |
| US11717584B2 (en) | 2019-05-31 | 2023-08-08 | Fermi Research Alliance, Llc | Supported X-ray horn for controlling e-beams |
| US10880984B2 (en) | 2019-05-31 | 2020-12-29 | Fermi Research Alliance, Llc | Permanent magnet e-beam/x-ray horn |
| CN114007657A (zh) * | 2019-06-25 | 2022-02-01 | Fka分销有限公司 | Uv消毒装置 |
| US11969203B2 (en) | 2020-02-14 | 2024-04-30 | Covidien Lp | Colpotomy system with applied energy |
| WO2022032283A2 (en) | 2020-08-07 | 2022-02-10 | Alpheus Medical, Inc. | Ultrasound arrays for enhanced sonodynamic therapy for treating cancer |
| DE202021104579U1 (de) * | 2020-11-20 | 2022-02-23 | Medlight Gmbh | Liebeskugel |
| USD968603S1 (en) * | 2021-01-11 | 2022-11-01 | Lumenis Be Ltd. | Tip for vaginal treatment device |
| USD968604S1 (en) * | 2021-01-11 | 2022-11-01 | Lumenis Be Ltd. | Device for vaginal treatment |
| US11547869B2 (en) * | 2021-04-15 | 2023-01-10 | Light Tree Ventures Holding B.V. | Shape compliant wearable photo-dynamic therapy (PDT) pad |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5019744Y1 (https=) * | 1970-12-03 | 1975-06-16 | ||
| JPS5810067A (ja) * | 1981-07-09 | 1983-01-20 | オリンパス光学工業株式会社 | 医療用カプセル |
| JPS6019744A (ja) | 1983-07-15 | 1985-01-31 | Kawasaki Steel Corp | α−テトラロンの製造方法 |
| US4858624A (en) | 1988-02-24 | 1989-08-22 | Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn | Device and method for intravaginal, barrier-type prevention of conception and infection |
| JP3157011B2 (ja) | 1991-06-29 | 2001-04-16 | マツダ株式会社 | ウィンド開閉制御装置 |
| IT1255984B (it) | 1991-12-27 | 1995-11-17 | Fabio Marchesi | Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus |
| US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
| AU4659096A (en) | 1995-01-30 | 1996-08-21 | Angiomedics Ii Incorporated | Photolytic drug delivery systems |
| US5674239A (en) | 1995-02-21 | 1997-10-07 | Zadini; Filiberto P. | Intravaginal balloon for blood leakage prevention |
| ATE202076T1 (de) | 1995-03-10 | 2001-06-15 | Photocure Asa | Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie |
| RU2512U1 (ru) * | 1995-06-16 | 1996-08-16 | Научный центр сердечно-сосудистой хирургии РАМН | Светодиодное устройство для фотодинамической терапии |
| DE29611520U1 (de) | 1996-07-02 | 1996-09-05 | Wilden, Lutz, Dr.med., 94051 Hauzenberg | Elektrischer Vaginalapplikator |
| GB9700396D0 (en) * | 1997-01-10 | 1997-02-26 | Photocure As | Photochemotherapeutic compositions |
| US5827186A (en) | 1997-04-11 | 1998-10-27 | Light Sciences Limited Partnership | Method and PDT probe for minimizing CT and MRI image artifacts |
| GB9721506D0 (en) | 1997-10-10 | 1997-12-10 | Virulite Limited | Treatment of diseases |
| GB2370992B (en) | 2000-03-23 | 2002-11-20 | Photo Therapeutics Ltd | Therapeutic light source and method |
| GB0010686D0 (en) | 2000-05-03 | 2000-06-28 | Zinn Shiri | Stimulatory device |
| US6551346B2 (en) | 2000-05-17 | 2003-04-22 | Kent Crossley | Method and apparatus to prevent infections |
| GB0018527D0 (en) | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
| GB0018528D0 (en) | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| US6622049B2 (en) | 2000-10-16 | 2003-09-16 | Remon Medical Technologies Ltd. | Miniature implantable illuminator for photodynamic therapy |
| US7107996B2 (en) | 2001-04-10 | 2006-09-19 | Ganz Robert A | Apparatus and method for treating atherosclerotic vascular disease through light sterilization |
| GB0118251D0 (en) | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
| US20040043349A1 (en) | 2002-08-27 | 2004-03-04 | Chu-Yuan Liao | Illuminated mouthpiece |
| JP4057437B2 (ja) * | 2003-02-04 | 2008-03-05 | 株式会社東海理化電機製作所 | 携帯機 |
| US7252677B2 (en) | 2003-03-14 | 2007-08-07 | Light Sciences Oncology, Inc. | Light generating device to intravascular use |
| US7144247B2 (en) | 2003-04-25 | 2006-12-05 | Oralum, Llc | Hygienic treatments of structures in body cavities |
| US7135034B2 (en) | 2003-11-14 | 2006-11-14 | Lumerx, Inc. | Flexible array |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| US20050239018A1 (en) | 2004-04-27 | 2005-10-27 | Scott Green | Intraoral bite spacer and illumination apparatus |
| CA2491249A1 (en) * | 2004-12-17 | 2006-06-17 | Bruce Murison | Electro-mechanical sexual stimulation device |
| US7384403B2 (en) | 2004-12-17 | 2008-06-10 | Depuy Products, Inc. | Wireless communication system for transmitting information from a medical device |
| CA2602835A1 (en) | 2005-03-31 | 2006-10-05 | Esther Mayer | Probe device, system and method for photobiomodulation of tissue lining a body cavity |
| US20070260231A1 (en) | 2005-04-21 | 2007-11-08 | Ondine International, Ltd. | Optical probe for delivery of light |
| US20070149903A1 (en) * | 2005-12-22 | 2007-06-28 | Nanma Manufacturing Co. Ltd. | Massage apparatus with exchangeable actuators |
| DE102006001736A1 (de) | 2006-01-13 | 2007-07-26 | Margull, Matthias, Dipl.-Ing. | Vorrichtung zur Applikation von monochromatischem Licht in Körperöffnungen |
| GB0608315D0 (en) | 2006-04-27 | 2006-06-07 | Univ St Andrews | Light emitting device for use in therapeutic and/or cosmetic treatment |
| US7950396B2 (en) | 2006-04-28 | 2011-05-31 | Ondine International Holdings Ltd. | Treatment for otitis externa |
| US8021148B2 (en) | 2006-05-03 | 2011-09-20 | Forsyth Dental Infirmary For Children | Intraoral light-emitting device |
| US8057464B2 (en) | 2006-05-03 | 2011-11-15 | Light Sciences Oncology, Inc. | Light transmission system for photoreactive therapy |
| US8088122B2 (en) | 2006-08-17 | 2012-01-03 | George Y. Choi | Optical ear infection treatment device and method |
| US8292935B2 (en) | 2006-09-12 | 2012-10-23 | Bistitec Pharma Marketing Ltd | Photonic device and method for treating cervical dysplasia |
| GB0700580D0 (en) | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
| CN101293124B (zh) * | 2007-04-29 | 2010-09-08 | 曾世一 | 一种阴部光照装置 |
| JP2009261647A (ja) * | 2008-04-25 | 2009-11-12 | Hoya Corp | カプセル内視鏡 |
| GB0816027D0 (en) | 2008-09-03 | 2008-10-08 | Lumicure Ltd | Controlled light emitting apparatus |
| GB0900461D0 (en) * | 2009-01-12 | 2009-02-11 | Photocure Asa | Photodynamic therapy device |
| RU2526803C2 (ru) | 2009-06-11 | 2014-08-27 | ФотоКьюэр АСА | Полутвердые композиции и фармацевтические продукты |
| US20110190580A1 (en) * | 2009-09-28 | 2011-08-04 | Bennett James D | Analysis engine within a network supporting intravaginal monitoring |
| WO2011159906A2 (en) * | 2010-06-17 | 2011-12-22 | InControl Medical, LLC | Urinary incontinence device and method and stimulation device and method |
| JP5991970B2 (ja) | 2010-07-09 | 2016-09-14 | フォトキュア エイエスエイ | 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置 |
| CN102170606A (zh) * | 2011-06-02 | 2011-08-31 | 江苏贝泰福医疗科技有限公司 | 一种深耳道自适应变形听力装置 |
| US8801600B2 (en) * | 2012-03-14 | 2014-08-12 | Ralph Zipper | Sexual stimulation device using light therapy |
-
2013
- 2013-04-09 GB GB201306369A patent/GB201306369D0/en not_active Ceased
-
2014
- 2014-04-09 US US14/783,240 patent/US9974974B2/en active Active
- 2014-04-09 NZ NZ630238A patent/NZ630238A/en unknown
- 2014-04-09 KR KR1020157031841A patent/KR102295433B1/ko active Active
- 2014-04-09 CN CN201480020424.2A patent/CN105307722B/zh active Active
- 2014-04-09 BR BR112015025474-8A patent/BR112015025474B1/pt active IP Right Grant
- 2014-04-09 RU RU2015144640A patent/RU2705606C2/ru not_active Application Discontinuation
- 2014-04-09 AU AU2014253175A patent/AU2014253175B2/en active Active
- 2014-04-09 CA CA2908787A patent/CA2908787C/en active Active
- 2014-04-09 MX MX2015014214A patent/MX375495B/es active IP Right Grant
- 2014-04-09 EP EP14715950.3A patent/EP2983780B1/en active Active
- 2014-04-09 JP JP2016506954A patent/JP2016518904A/ja active Pending
- 2014-04-09 SG SG11201508117YA patent/SG11201508117YA/en unknown
- 2014-04-09 ES ES14715950T patent/ES2837025T3/es active Active
- 2014-04-09 WO PCT/EP2014/057148 patent/WO2014166993A1/en not_active Ceased
-
2015
- 2015-10-07 CL CL2015002987A patent/CL2015002987A1/es unknown
- 2015-10-09 ZA ZA2015/07529A patent/ZA201507529B/en unknown
-
2018
- 2018-05-21 US US15/985,214 patent/US10485985B2/en active Active
-
2019
- 2019-02-20 JP JP2019028157A patent/JP6781287B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150140756A (ko) | 2015-12-16 |
| GB201306369D0 (en) | 2013-05-22 |
| EP2983780B1 (en) | 2020-10-28 |
| JP6781287B2 (ja) | 2020-11-04 |
| ES2837025T3 (es) | 2021-06-29 |
| AU2014253175A1 (en) | 2015-11-26 |
| CN105307722A (zh) | 2016-02-03 |
| CL2015002987A1 (es) | 2016-12-09 |
| JP2016518904A (ja) | 2016-06-30 |
| JP2019088903A (ja) | 2019-06-13 |
| ZA201507529B (en) | 2016-12-21 |
| NZ630238A (en) | 2017-04-28 |
| CA2908787A1 (en) | 2014-10-16 |
| RU2705606C2 (ru) | 2019-11-11 |
| KR102295433B1 (ko) | 2021-08-30 |
| RU2015144640A (ru) | 2017-05-15 |
| CA2908787C (en) | 2022-08-23 |
| US9974974B2 (en) | 2018-05-22 |
| MX375495B (es) | 2025-03-06 |
| US20180264283A1 (en) | 2018-09-20 |
| US20160045757A1 (en) | 2016-02-18 |
| SG11201508117YA (en) | 2015-10-29 |
| EP2983780A1 (en) | 2016-02-17 |
| CN105307722B (zh) | 2018-02-27 |
| BR112015025474A2 (pt) | 2017-07-18 |
| HK1213828A1 (en) | 2016-07-15 |
| MX2015014214A (es) | 2016-01-08 |
| US10485985B2 (en) | 2019-11-26 |
| WO2014166993A1 (en) | 2014-10-16 |
| AU2014253175B2 (en) | 2019-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10485985B2 (en) | Irradiation device | |
| ES2552662T3 (es) | Dispositivo de irradiación | |
| ES2813414T3 (es) | Aparato de irradiación | |
| HK1213828B (en) | Irradiation device | |
| HK1225676B (zh) | 放射装置、套件和混合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/04/2014, OBSERVADAS AS CONDICOES LEGAIS |